This session will explore how quantum computing is poised to redefine the frontiers of drug discovery by solving complex molecular and optimization problems that exceed the limits of classical computing. Leading experts in AI-driven drug design, quantum algorithms, and computational chemistry will discuss how emerging quantum methods can accelerate target identification and compound optimization. Attendees can expect to hear about the practical challenges of integrating quantum computing into today’s pharmaceutical R&D pipelines and highlight early collaborations demonstrating how quantum advantage could shorten timelines and improve accuracy in the search for new therapies. Attendees will leave with a view of where quantum can create real R&D value in the near term, and what milestones must be reached to unlock breakthrough impact at scale.